Amgen Inc.
CRYSTALLINE ANTIBODY FORMULATIONS
Last updated:
Abstract:
Described herein are anti-PCSK9 antibody crystals, methods of making such antibody crystals and formulations comprising the antibody crystals.
Status:
Application
Type:
Utility
Filling date:
24 Feb 2020
Issue date:
24 Sep 2020